157 related articles for article (PubMed ID: 24746200)
1. Support for p63 expression as an adverse prognostic marker in Merkel cell carcinoma: report on a Canadian cohort.
Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2014 May; 45(5):952-60. PubMed ID: 24746200
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: Merkel cell polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome.
Dabner M; McClure RJ; Harvey NT; Budgeon CA; Beer TW; Amanuel B; Wood BA
Pathology; 2014 Apr; 46(3):205-10. PubMed ID: 24614722
[TBL] [Abstract][Full Text] [Related]
3. Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors.
Lai JH; Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2015 Sep; 46(9):1290-6. PubMed ID: 26099430
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical prognostication of Merkel cell carcinoma: p63 expression but not polyomavirus status correlates with outcome.
Hall BJ; Pincus LB; Yu SS; Oh DH; Wilson AR; McCalmont TH
J Cutan Pathol; 2012 Oct; 39(10):911-7. PubMed ID: 22882157
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
6. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
[TBL] [Abstract][Full Text] [Related]
7. Expression of p63 is the sole independent marker of aggressiveness in localised (stage I-II) Merkel cell carcinomas.
Asioli S; Righi A; de Biase D; Morandi L; Caliendo V; Picciotto F; Macripò G; Maletta F; di Cantogno LV; Chiusa L; Eusebi V; Bussolati G
Mod Pathol; 2011 Nov; 24(11):1451-61. PubMed ID: 21765392
[TBL] [Abstract][Full Text] [Related]
8. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
10. p63 expression as a new prognostic marker in Merkel cell carcinoma.
Asioli S; Righi A; Volante M; Eusebi V; Bussolati G
Cancer; 2007 Aug; 110(3):640-7. PubMed ID: 17599745
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites.
Ly TY; Walsh NM; Pasternak S
Hum Pathol; 2012 Apr; 43(4):557-66. PubMed ID: 21940035
[TBL] [Abstract][Full Text] [Related]
12. Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma.
Higaki-Mori H; Kuwamoto S; Iwasaki T; Kato M; Murakami I; Nagata K; Sano H; Horie Y; Yoshida Y; Yamamoto O; Adachi K; Nanba E; Hayashi K
Hum Pathol; 2012 Dec; 43(12):2282-91. PubMed ID: 22795182
[TBL] [Abstract][Full Text] [Related]
13. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.
Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P
Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma: histologic features and prognosis.
Andea AA; Coit DG; Amin B; Busam KJ
Cancer; 2008 Nov; 113(9):2549-58. PubMed ID: 18798233
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
[TBL] [Abstract][Full Text] [Related]
17. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant local irradiation for Merkel cell carcinoma.
Lewis KG; Weinstock MA; Weaver AL; Otley CC
Arch Dermatol; 2006 Jun; 142(6):693-700. PubMed ID: 16785371
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary?
Clark JR; Veness MJ; Gilbert R; O'Brien CJ; Gullane PJ
Head Neck; 2007 Mar; 29(3):249-57. PubMed ID: 17163472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
